Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certa

Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certain Patients With COPD

Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.

Related Keywords

, International Journal Of Chronic Obstructive Pulmonary Disease , International Journal , Chronic Obstructive Pulmonary Disease , Copd , Docs , Il5 , Il5r , Exacerbations ,

© 2025 Vimarsana